326 results on '"Pratt, Victoria M."'
Search Results
2. DPYD Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, American College of Medical Genetics and Genomics, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, Pharmacogenomics Knowledgebase, and Pharmacogene Variation Consortium
3. CYP3A4 and CYP3A5 Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase
4. Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology
5. 2024 Updates to American Medical Association's Current Procedural Terminology Codes for Oncology Panel Testing
6. Pharmacogenetic testing in the Veterans Health Administration (VHA): policy recommendations from the VHA Clinical Pharmacogenetics Subcommittee
7. Design and rationale of GUARDD-US: A pragmatic, randomized trial of genetic testing for APOL1 and pharmacogenomic predictors of antihypertensive efficacy in patients with hypertension
8. Implementing a pragmatic clinical trial to tailor opioids for chronic pain on behalf of the IGNITE ADOPT PGx investigators.
9. Expanding evidence leads to new pharmacogenomics payer coverage
10. DPYDGenotyping Recommendations
11. Clinical Opportunities for Germline Pharmacogenetics and Management of Drug-Drug Interactions in Patients With Advanced Solid Cancers
12. Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing
13. Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
14. Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE Network
15. Chapter 42 - Germline pharmacogenomics in cancer treatment
16. Correction: Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE Network
17. Lessons Learned When Introducing Pharmacogenomic Panel Testing into Clinical Practice
18. Translating pharmacogenetics from research to routine clinical practice – a survey of the IGNITE Network
19. Analytical validity of a genotyping assay for use with personalized antihypertensive and chronic kidney disease therapy
20. Pharmacogenetics
21. Contributors
22. Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing
23. Characterization of Reference Materials for TPMT and NUDT15
24. TPMT and NUDT15 Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase
25. Correction: Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE Network
26. Response to Gammal et al.
27. List of Contributors
28. Allelic decomposition and exact genotyping of highly polymorphic and structurally variant genes
29. CYP2C8, CYP2C9, and CYP2C19 Characterization Using Next-Generation Sequencing and Haplotype Analysis: A GeT-RM Collaborative Project
30. Abstract 1151: Pharmacogenomics genotyping from clinical somatic whole exome sequencing: Aldy, a computational tool
31. Analytical Validation of a Computational Method for Pharmacogenetic Genotyping from Clinical Whole Exome Sequencing
32. CYP2C8, CYP2C9, and CYP2C19 Characterization Using Next-Generation Sequencing and Haplotype Analysis
33. Clinical pharmacogenomic testing and reporting: A technical standard of the American College of Medical Genetics and Genomics (ACMG)
34. Correction: Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE Network
35. PharmVar GeneFocus: CYP3A5
36. Pharmacogenomics of Hypertension in CKD: The CKD-PGX Study
37. List of contributors
38. Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing
39. Characterization of 107 Genomic DNA Reference Materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: A GeT-RM and Association for Molecular Pathology Collaborative Project
40. Recommendations for Clinical CYP2D6 Genotyping Allele Selection
41. CLINICAL OPPORTUNITIES FOR GERMLINE PHARMACOGENETICS AND MANAGEMENT OF DRUG-DRUG INTERACTIONS IN PATIENTS WITH ADVANCED SOLID CANCERS
42. Characterization of Reference Materials with an Association for Molecular Pathology Pharmacogenetics Working Group Tier 2 Status: CYP2C9, CYP2C19, VKORC1, CYP2C Cluster Variant, and GGCX
43. PharmVar GeneFocus: CYP2C9
44. Establishing the value of genomics in medicine: the IGNITE Pragmatic Trials Network
45. FDAʼs draft guidance on laboratory-developed tests increases clinical and economic risk to adoption of pharmacogenetic testing
46. Development and Characterization of Reference Materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 Genetic Testing
47. CpG Methylation Analysis—Current Status of Clinical Assays and Potential Applications in Molecular Diagnostics: A Report of the Association for Molecular Pathology
48. Identification of Cystic Fibrosis Variants by Polymerase Chain Reaction/Oligonucleotide Ligation Assay
49. Development of Genomic Reference Materials for Cystic Fibrosis Genetic Testing
50. Clinician Perspectives about Molecular Genetic Testing for Heritable Conditions and Development of a Clinician-Friendly Laboratory Report
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.